Medulloblastoma: WHO 2021 and Beyond.
Cotter JA, Hawkins C.
Pediatr Dev Pathol. 2022 Jan-Feb;25(1):23-33. doi: 10.1177/10935266211018931.
[Medulloblastoma].
Yamaguchi S, Fujimura M.
No Shinkei Geka. 2023 Sep;51(5):858-866. doi: 10.11477/mf.1436204827.
Medulloblastoma.
Bartlett F, Kortmann R, Saran F.
Clin Oncol (R Coll Radiol). 2013 Jan;25(1):36-45. doi: 10.1016/j.clon.2012.09.008. Epub 2012 Dec 11.
Medulloblastoma.
Katsetos CD, Burger PC.
Semin Diagn Pathol. 1994 May;11(2):85-97.
Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
Archer TC, Mahoney EL, Pomeroy SL.
Neurotherapeutics. 2017 Apr;14(2):265-273. doi: 10.1007/s13311-017-0526-y.
[The medulloblastoma].
Figols-Ladrón de Guevara J, Lafuente-Sánchez JV.
Rev Neurol. 2006 Aug 16-31;43(4):213-7.
Medulloblastoma: Clinical presentation.
Vinchon M, Leblond P.
Neurochirurgie. 2021 Feb;67(1):23-27. doi: 10.1016/j.neuchi.2019.04.006. Epub 2019 Sep 5.
[Molecular Classification of Medulloblastoma].
Suzuki H.
No Shinkei Geka. 2025 Nov;53(6):1060-1066. doi: 10.11477/mf.030126030530061060.
Evolving Biology and Therapy of WNT-Activated Medulloblastoma.
Mikkelsen MK, Pinto SN, Chiang J, Shimony N, Gajjar A.
J Natl Compr Canc Netw. 2025 Sep 18;23(10):e257061. doi: 10.6004/jnccn.2025.7061.
Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse.
Zhang L, He X, Liu X, Zhang F, Huang LF, Potter AS, Xu L, Zhou W, Zheng T, Luo Z, Berry KP, Pribnow A, Smith SM, Fuller C, Jones BV, Fouladi M, Drissi R, Yang ZJ, Gustafson WC, Remke M, Pomeroy SL, Girard EJ, Olson JM, Morrissy AS, Vladoiu MC, Zhang J, Tian W, Xin M, Taylor MD, Potter SS, Roussel MF, Weiss WA, Lu QR.
Cancer Cell. 2019 Sep 16;36(3):302-318.e7. doi: 10.1016/j.ccell.2019.07.009. Epub 2019 Aug 29.
